Pharma Journalist 9038 posts 0 comments

Charles River Laboratories International announced that it has completed the previously announced acquisition of HemaCare Corporation for approximately $380 million in cash, or $25.40…
Read More...

Leap Therapeutics and BeiGene announced an exclusive option and license agreement for the clinical development and commercialization of DKN-01, Leap's anti-Dickkopf-1 (DKK1) antibody,…
Read More...

SMi reports: The countdown begins for the long anticipated 9th Annual Pharmaceutical Microbiology UK Conference in London this month. The 9th Annual Pharmaceutical Microbiology UK…
Read More...

SMi Reports: Co-chairs invite senior pharmaceutical professionals to join SMi's 3D Cell Culture Conference, taking place in February 2020 in London. SMi’s 4th annual 3D Cell Culture…
Read More...

AstraZeneca announced that it has agreed to sell the commercial rights to Arimidex (anastrozole) and Casodex (bicalutamide) in a number of European, African and other countries1 to…
Read More...

PharmaMar and Jazz Pharmaceuticals plc announced that PharmaMar and Jazz Pharmaceuticals Ireland Limited have entered into an exclusive license agreement for lurbinectedin in the United…
Read More...

Genmab A/S and CureVac AG announced that Genmab and CureVac have entered into a research collaboration and license agreement. This strategic partnership will focus on the research and…
Read More...

Achillion Pharmaceuticals announced that its shareholders have approved the acquisition of Achillion by Alexion Pharmaceuticals. Achillion continues to expect the transaction to close…
Read More...

Dicerna Pharmaceuticals, Inc. announced the successful closing of the research collaboration and licensing agreement between Dicerna and Roche following expiration of the waiting period…
Read More...

BC Platforms announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA. The round was led by IQVIA in conjunction with…
Read More...